Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone

Soriano F, Tauch A (2008)
CLINICAL MICROBIOLOGY AND INFECTION 14(7): 632-643.

Journal Article | Published | English

No fulltext has been uploaded

Author
;
Abstract
Corynebacterium urealyticum, formerly known as coryneform CDC group D2, was first recognized to be involved in human infections 30 years ago. It is a slow-growing, lipophilic, asaccharolytic and usually multidrug-resistant organism with potent urease activity. Its cell wall peptidoglycan, menaquinone, mycolic and cellular fatty acid composition is consistent with that of the genus Corynebacterium. DNA-DNA hybridization studies and 16S rDNA sequencing analysis have been used to determine the degree of relatedness of C. urealyticum to other corynebacterial species. The genome of the type strain consists of a circular chromosome with a size of 2 369 219 bp and a mean G + C content of 64.2%, and analysis of its genome explains the bacterium's lifestyle. C. urealyticum is a common skin colonizer of hospitalized elderly individuals who are receiving broad-spectrum antibiotics. It is an opportunistic pathogen causing mainly acute cystitis, pyelonephritis, encrusted cystitis, and encrusted pyelitis. More infrequently, it causes other infections, but mainly in patients with urological diseases. Infections are more common in males than in females, and treatment requires administration of antibiotics active against the organism in vitro, mainly glycopeptides, as well as surgical intervention, the latter mostly in cases of chronic infection. Mortality directly associated with infection by this organism is not frequent, but encrusted pyelitis in kidney-recipient patients may cause graft loss. The outcome of infection by this organism is reasonably good if the microbiological diagnosis is made and patients are treated appropriately.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Soriano F, Tauch A. Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. CLINICAL MICROBIOLOGY AND INFECTION. 2008;14(7):632-643.
Soriano, F., & Tauch, A. (2008). Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. CLINICAL MICROBIOLOGY AND INFECTION, 14(7), 632-643.
Soriano, F., and Tauch, A. (2008). Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. CLINICAL MICROBIOLOGY AND INFECTION 14, 632-643.
Soriano, F., & Tauch, A., 2008. Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. CLINICAL MICROBIOLOGY AND INFECTION, 14(7), p 632-643.
F. Soriano and A. Tauch, “Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone”, CLINICAL MICROBIOLOGY AND INFECTION, vol. 14, 2008, pp. 632-643.
Soriano, F., Tauch, A.: Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. CLINICAL MICROBIOLOGY AND INFECTION. 14, 632-643 (2008).
Soriano, F., and Tauch, Andreas. “Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone”. CLINICAL MICROBIOLOGY AND INFECTION 14.7 (2008): 632-643.
This data publication is cited in the following publications:
This publication cites the following data publications:

15 Citations in Europe PMC

Data provided by Europe PubMed Central.

Corynebacterium urealyticum: a comprehensive review of an understated organism.
Salem N, Salem L, Saber S, Ismail G, Bluth MH., Infect Drug Resist 8(), 2015
PMID: 26056481
Genome informatics and vaccine targets in Corynebacterium urealyticum using two whole genomes, comparative genomics, and reverse vaccinology.
Guimaraes L, Soares S, Trost E, Blom J, Ramos R, Silva A, Barh D, Azevedo V., BMC Genomics 16 Suppl 5(), 2015
PMID: 26041051
Complete Genome Assembly of Corynebacterium sp. Strain ATCC 6931.
Daligault HE, Davenport KW, Minogue TD, Bishop-Lilly KA, Bruce DC, Chain PS, Coyne SR, Frey KG, Jaissle J, Koroleva GI, Ladner JT, Li PE, Meincke L, Munk AC, Palacios GF, Redden CL, Johnson SL., Genome Announc 2(5), 2014
PMID: 25342684
Nephrolithiasis by Corynebacterium urealyticum infection: literature review and case report.
Cappuccino L, Bottino P, Torricella A, Pontremoli R., J. Nephrol. 27(2), 2014
PMID: 24563271
Complete Genome Sequence of Corynebacterium urealyticum Strain DSM 7111, Isolated from a 9-Year-Old Patient with Alkaline-Encrusted Cystitis.
Guimaraes LC, Soares SC, Albersmeier A, Blom J, Jaenicke S, Azevedo V, Soriano F, Tauch A, Trost E., Genome Announc 1(3), 2013
PMID: 23704183
Successful treatment of encrusted cystitis associated with Staphylococcus pseudintermedius infection in the urinary bladder of a dog.
Biegen VR, Slusser PG, Fischetti AJ, Geist MR., J. Am. Vet. Med. Assoc. 242(6), 2013
PMID: 23445291
Encrusted cystitis and pyelitis.
Anagnostou N, Siddins M, Gordon DL., Intern Med J 42(5), 2012
PMID: 22616968
Complete genome sequence, lifestyle, and multi-drug resistance of the human pathogen Corynebacterium resistens DSM 45100 isolated from blood samples of a leukemia patient.
Schroder J, Maus I, Meyer K, Wordemann S, Blom J, Jaenicke S, Schneider J, Trost E, Tauch A., BMC Genomics 13(), 2012
PMID: 22524407
Encrusted cystitis.
Johnson MH, Strope SA., Urology 79(3), 2012
PMID: 22386439
N-substituted aminomethanephosphonic and aminomethane-P-methylphosphinic acids as inhibitors of ureases.
Berlicki L, Bochno M, Grabowiecka A, Bialas A, Kosikowska P, Kafarski P., Amino Acids 42(5), 2012
PMID: 21559954
The beta-lactam-sensitive D,D-carboxypeptidase activity of Pbp4 controls the L,D and D,D transpeptidation pathways in Corynebacterium jeikeium.
Lavollay M, Arthur M, Fourgeaud M, Dubost L, Marie A, Riegel P, Gutmann L, Mainardi JL., Mol. Microbiol. 74(3), 2009
PMID: 19807868
Isolation of Corynebacterium ureicelerivorans from normally sterile sites in humans.
Fernandez-Natal MI, Saez-Nieto JA, Valdezate S, Rodriguez-Pollan RH, Lapena S, Cachon F, Soriano F., Eur. J. Clin. Microbiol. Infect. Dis. 28(6), 2009
PMID: 19089476
In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium.
Fernandez-Roblas R, Adames H, Martin-de-Hijas NZ, Almeida DG, Gadea I, Esteban J., Int. J. Antimicrob. Agents 33(5), 2009
PMID: 19153032
In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
Soriano F, Huelves L, Naves P, Rodriguez-Cerrato V, del Prado G, Ruiz V, Ponte C., J. Antimicrob. Chemother. 63(2), 2009
PMID: 19056748

113 References

Data provided by Europe PubMed Central.

Endocarditis caused by Corynebacterium group D2.
Ena J, Berenguer J, Pelaez T, Bouza E., J. Infect. 22(1), 1991
PMID: 2002238
[Prosthetic valve endocarditis caused by Corynebacterium urealyticum]
Notario R, Borda N, Gambande T., Medicina (B Aires) 56(1), 1996
PMID: 8734934
Corynebacterium group D2 and urolithiasis in a boy with megacalycosis.
Nadal D, Schwobel M, von Graevenitz A., Infection 16(4), 1988
PMID: 3053458
Corynebacterium group D2 infection of a complex renal cyst in a debilitated patient.
Ohl CA, Tribble DR., Clin. Infect. Dis. 14(5), 1992
PMID: 1600022
Pericarditis caused by Corynebacterium urealyticum.
Ojeda-Vargas M, Gonzalez-Fernandez MA, Romero D, Cedres A, Monzon-Moreno C., Clin. Microbiol. Infect. 6(10), 2000
PMID: 11168052
Corynebacterium induced urethral incrustation.
Park JM, Faerber GJ., J. Urol. 151(6), 1994
PMID: 8189584
Osteomyelitis due to Corynebacterium group D2.
Chomarat M, Breton P, Dubost J., Eur. J. Clin. Microbiol. Infect. Dis. 10(1), 1991
PMID: 2009880
A necrotic soft-tissue lesion due to Corynebacterium urealyticum in a neutropenic child.
Saavedra J, Rodriguez JN, Fernandez-Jurado A, Vega MD, Pascual L, Prados D., Clin. Infect. Dis. 22(5), 1996
PMID: 8722946
Evaluation of API Coryne in comparison with conventional methods for identifying coryneform bacteria.
Freney J, Duperron MT, Courtier C, Hansen W, Allard F, Boeufgras JM, Monget D, Fleurette J., J. Clin. Microbiol. 29(1), 1991
PMID: 1993764
Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients.
Domann E, Hong G, Imirzalioglu C, Turschner S, Kuhle J, Watzel C, Hain T, Hossain H, Chakraborty T., J. Clin. Microbiol. 41(12), 2003
PMID: 14662931
16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates.
Drancourt M, Bollet C, Carlioz A, Martelin R, Gayral JP, Raoult D., J. Clin. Microbiol. 38(10), 2000
PMID: 11015374
Ribosomal DNA sequencing for identification of aerobic gram-positive rods in the clinical laboratory (an 18-month evaluation).
Bosshard PP, Abels S, Zbinden R, Bottger EC, Altwegg M., J. Clin. Microbiol. 41(9), 2003
PMID: 12958237

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 18558935
PubMed | Europe PMC

Search this title in

Google Scholar